Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
Medtronic's latest partnership with Merit Medical Systems introduces the groundbreaking ViaVerte™ BVNA system—an innovative solution for chronic vertebrogenic pain
Led by researchers at the Vanderbilt University Medical Center, a new study reports that Optellum's FDA-cleared Lung Cancer Prediction (LCP) AI assisted risk stratification for indeterminate lung nodules is cost-effective from a US payer perspective. Optellum's LCP AI supports more consistent long nodule management and helps enable earlier diagnosis of...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD
The study, published in The March 2026 edition of Federal Practitioner, reported an association between thermal therapy use and reduced opioid and benzodiazepine utilization, as well as lower healthcare utilization in the patient population.
The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b trial in ALS, including slower functional decline, reduced risk of ALS-related complications, and modulation of disease-relevant biomarkers
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patients
Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases
Redipor® Legionella agar plate range - specifically designed to support the detection and enumeration of Legionella in water samples
Expanded 10-plus-year collaboration will leverage Medidata Experiences, enabling Sanofi to streamline operations, refine data quality, and enhance patient care
RC Capital, Mutual Capital Partners and Western Alliance Bank reinforce long-term confidence in Catalyst’s vision and leadership; Dr. Theodore Blaine joins Catalyst board of directors

Discover how at-home diagnostics are transforming the detection of undiagnosed sleep apnea and enabling essential treatments.

Explore groundbreaking PTSD treatment options that are drug-free and trauma-free, offering hope for recovery through advanced medical devices.

With the right mix of planning, monitoring and data management, carriers can successfully deliver the tools and treatments that make the personalized medicine revolution possible.
The study is designed to compare genicular artery embolization (GAE) with Nexsphere-F™ to intra-articular corticosteroid injections, with the primary goal of assessing both safety and efficacy in patients with painful knee osteoarthritis. Nexsphere-F™ has already received multiple key U.S. regulatory designations, including FDA Breakthrough Device Designation, CMS IDE Category B approval, and participation in the TAP (Total Product Lifecycle Advisory Program).
The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays (D-MNA) representing ~$2 billion in potential market opportunity
Veteran SaaS and Fintech executive brings deep expertise in scaling, capital strategy, and M&A to drive Meevo’s continued growth

New leaders will showcase Salt AI’s adaptive pipeline at the AI Drug Discovery & Development Summit.
A highly experienced executive with deep scientific expertise, who has helped lead numerous private and public cell therapy biotechs, establishing corporate structures and raising funds

DREAM OCT is able to cover an ultrawide field single scan which delivers a 130° OCTA image. DREAM OCT™ swept-source 12 mm super-depth scanning allows superior imaging of the choroid and retina, and a large portion of the vitreous space.
Medical diagnostics is undergoing a rapid transformation, and United Imaging is at the forefront of this change. Through a combination of advanced technology, artificial intelligence and thoughtful equipment design, the company is redefining the standards of modern healthcare.

“The future of healthcare is in the data. At ZEISS, we are delivering digital innovation to help shape the future of ophthalmology, investing in research methods that empower clinicians and researchers in balancing their clinical care and research requirements,” says Euan S. Thomson, Ph.D., Head of the Digital Business Unit for ZEISS Medical Technology. “The introduction of the ZEISS RDP reflects our commitment to advancing ophthalmic care through smarter, AI-powered tools.”

The agreement was formalized during a signing ceremony at the 5th Asia Summit on Global Health, with Dr. Karim S. Karim, Chief Technology Officer of KA Imaging, and Dr. Andrew Hui, Chief Operating Officer of Canossa Hospital, as signatories.

This milestone puts S.L. Raheja Hospital, Mahim, at the forefront of cardiac care in Mumbai, with one of Mumbai’s most advanced Structural Heart Programs.

Da Vinci 5 is the newest entry to the da Vinci portfolio of systems, which also includes da Vinci X®, da Vinci Xi®, and da Vinci SP®. The system can be used for minimally invasive surgical procedures for urology, gynecology, thoracic, and general surgeries.

Surgeons need a wide range of tools to do their job well, including devices for diagnosis, instruments for surgery robotic systems, and ways to manage tissue
In today’s highly connected world, the patient experience begins the moment a patient decides to seek care. The patient intake process is not just a formality; it’s the first clinical and administrative touchpoint that shapes how patients perceive their entire care experience

A ey fob door entry system offers a reliable, scalable solution designed to enhance both safety and efficiency in healthcare settings

Purifying proteins is a crucial step in ensuring the reliability and accuracy of experiments
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.